Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum

被引:99
作者
Hemphill, A. [1 ]
Vonlaufen, N. [1 ]
Naguleswaran, A. [1 ]
机构
[1] Univ Bern, Vetsuisse Fac, Inst Parasitol, CH-3012 Bern, Switzerland
关键词
Neospora caninum; host cell invasion; cell surface receptors; host cell modulation; stage conversion; murine model; vaccination;
D O I
10.1017/S0031182006000485
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Neospora caninum is an apicomplexan parasite that is closely related to Toxoplasma gondii, the causative agent of toxoplasmosis in humans and domestic animals. However, in contrast to T. gondii, N. caninum represents a major cause of abortion in cattle, pointing towards distinct differences in the biology of these two species. There are 3 distinct key features that represent potential targets for prevention of infection or intervention against disease caused by N. caninum. Firstly, tachyzoites are capable of infecting a large variety of host cells in vitro and in vivo. Secondly, the parasite exploits its ability to respond to alterations in living conditions by converting into another stage (tachyzoite-to-bradyzoite or vice versa). Thirdly, by analogy with T. gondii, this parasite has evolved mechanisms that modulate its host cells according to its own requirements, and these must, especially in the case of the bradyzoite stage, involve mechanisms that ensure long-term survival of not only the parasite but also of the host cell. In order to elucidate the molecular and cellular bases of these important features of N. caninum, cell culture-based approaches and laboratory animal models are being exploited. In this review, we will summarize the current achievements related to host cell and parasite cell biology, and will discuss potential applications for prevention of infection and/or disease by reviewing corresponding work performed in murine laboratory infection models and in cattle.
引用
收藏
页码:261 / 278
页数:18
相关论文
共 163 条
[1]   Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1 [J].
Alaeddine, F ;
Keller, N ;
Leepin, A ;
Hemphill, A .
JOURNAL OF PARASITOLOGY, 2005, 91 (03) :657-665
[2]   Mechanisms of innate resistance to Toxoplasma gondii infection [J].
Alexander, J ;
SchartonKersten, TM ;
Yap, G ;
Roberts, CW ;
Liew, FY ;
Sher, A .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1997, 352 (1359) :1355-1359
[3]   Immunogenicity of a killed whole Neospora caninum tachyzoite preparation formulated with different adjuvants [J].
Andrianarivo, AG ;
Choromanski, L ;
McDonough, SP ;
Packham, AE ;
Conrad, PA .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1999, 29 (10) :1613-1625
[4]  
Athanassakis I, 1996, DEV IMMUNOL, V4, P247
[5]   Comparison of the biological characteristics of two isolates of Neospora caninum [J].
Atkinson, R ;
Harper, PAW ;
Ryce, C ;
Morrison, DA ;
Ellis, JT .
PARASITOLOGY, 1999, 118 :363-370
[6]   Characterization of the first European isolate of Neospora caninum (Dubey, Carpenter, Speer, Topper and Uggla) [J].
Barber, JS ;
Holmdahl, OJM ;
Owen, MR ;
Guy, F ;
Uggla, A ;
Trees, AJ .
PARASITOLOGY, 1995, 111 :563-568
[7]   Interferon-γ and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice [J].
Baszler, TV ;
Long, MT ;
McElwain, TF ;
Mathison, BA .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1999, 29 (10) :1635-1646
[8]   Serological diagnosis of bovine neosporosis by Neospora caninum monoclonal antibody-based competitive inhibition enzyme-linked immunosorbent assay [J].
Baszler, TV ;
Knowles, DP ;
Dubey, JP ;
Gay, JM ;
Mathison, BA ;
McElwain, TF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (06) :1423-1428
[9]   Validation of a commercially available monoclonal antibody-based competitive-inhibition enzyme-linked immunosorbent assay for detection of serum antibodies to Neospora caninum in cattle [J].
Baszler, TV ;
Adams, S ;
Vander-Schalie, J ;
Mathison, BA ;
Kostovic, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) :3851-3857
[10]  
BECKERS CJ, 1999, J CELL BIOL, V27, P947